The role of stem cell therapies in degenerative lumbar spine disease: a review

Neurosurgical Review
David OehmeGraham Jenkin

Abstract

Degenerative conditions of the lumbar spine are extremely common. Ninety percent of people over the age of 60 years have degenerative change on imaging; however, only a small minority of people will require spine surgery (Hicks et al. Spine (Phila Pa 1976) 34(12):1301-1306, 2009). This minority, however, constitutes a core element of spinal surgery practice. Whilst the patient outcomes from spinal surgeries have improved in recent years, some patients will remain with pain and disability despite technically successful surgery. Advances in regenerative medicine and stem cell therapies, particularly the use of mesenchymal stem cells and allogeneic mesenchymal precursor cells, have led to numerous clinical trials utilising these cell-based therapies to treat degenerative spinal conditions. Through cartilage formation and disc regeneration, fusion enhancement or via modification of pain pathways, stem cells are well suited to enhance spinal surgery practice. This review will focus on the outcomes of lumbar spinal procedures and the role of stem cells in the treatment of degenerative lumbar conditions to enhance clinical practice. The current status of clinical trials utilising stem cell therapies will be discussed, providing clinic...Continue Reading

References

Oct 1, 1990·Acta Orthopaedica Scandinavica·C BarriosP Gillström
Nov 6, 1998·Science·J A ThomsonJ M Jones
Dec 10, 1999·Spine·G A LoupasisG Hartofilakidis
Nov 1, 2000·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·T Floyd, D Ohnmeiss
Dec 10, 2002·Reproductive Biomedicine Online·Alan Trounson
Dec 12, 2002·Molecular Biology of the Cell·Patricia A ZukMarc H Hedrick
Apr 4, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Songtao Shi, Stan Gronthos
Apr 21, 2004·Annals of Biomedical Engineering·Gwen CrevenstenSigurd Berven
Sep 16, 2004·Journal of Biomedical Materials Research. Part a·L Saad, M Spector
Jan 22, 2005·Clinical Orthopaedics and Related Research·Yin-Gang ZhangJun Li
May 6, 2005·Journal of Neurosurgery. Spine·Rudolf BertagnoliRegina Nanieva
May 10, 2005·Endocrine Development·Anna SpagnoliLynda O'Rear
May 27, 2005·Cell Research·Ren Qing FengZhen Quan Guo
Apr 6, 2006·The Journal of Bone and Joint Surgery. American Volume·Sally RobertsJanis Menage
Jul 20, 2006·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Hans Joerg MeiselOlivera Alasevic
Sep 20, 2006·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Günther PaesoldNorbert Boos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.